These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36148768)
1. TAFRO syndrome: A disease that known is half cured. Chen T; Feng C; Zhang X; Zhou J Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768 [TBL] [Abstract][Full Text] [Related]
2. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. Fujiwara Y; Ito K; Takamura A; Nagata K J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072 [TBL] [Abstract][Full Text] [Related]
4. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging. Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946 [TBL] [Abstract][Full Text] [Related]
5. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103 [TBL] [Abstract][Full Text] [Related]
6. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature. Zhou Q; Zhang Y; Zhou G; Zhu J BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930 [TBL] [Abstract][Full Text] [Related]
7. TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review. Grange L; Chalayer E; Boutboul D; Paul S; Galicier L; Gramont B; Killian M Autoimmun Rev; 2022 Aug; 21(8):103137. PubMed ID: 35803499 [TBL] [Abstract][Full Text] [Related]
9. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease. Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946 [TBL] [Abstract][Full Text] [Related]
10. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report. Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219 [TBL] [Abstract][Full Text] [Related]
11. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology. Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113 [TBL] [Abstract][Full Text] [Related]
12. Delayed diagnosis of TAFRO syndrome: A case report. Qiao Y; Zhang X; Xu R; Jia X; Wang Q Medicine (Baltimore); 2024 Aug; 103(31):e39148. PubMed ID: 39093747 [TBL] [Abstract][Full Text] [Related]
13. Pediatric TAFRO syndrome: A multi-institution case series illustrating clinical challenges and excellent outcomes. Johnson AK; Goteti S; Devald B; Mestnik S; Ghosh T; Williams R; Doughty ES; Linden MA; Beckman A; Williams T; Richardson K; Martinelli M Pediatr Blood Cancer; 2024 Oct; 71(10):e31234. PubMed ID: 39086111 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199 [TBL] [Abstract][Full Text] [Related]
16. [A case report of TAFRO syndrome]. Zhou GP; Zhou QY; Zhu JH Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):814-817. PubMed ID: 34393252 [TBL] [Abstract][Full Text] [Related]
17. TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report. Yamada M; Sada RM; Kashihara E; Okubo G; Matsushita S; Manabe A; Tagawa S; Akebo H; Miyake H; Hatta K J Infect Chemother; 2022 Jul; 28(7):1008-1011. PubMed ID: 35428576 [TBL] [Abstract][Full Text] [Related]
18. International definition of iMCD-TAFRO: future perspectives. Nishimura Y; Nishimura MF; Sato Y J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036 [TBL] [Abstract][Full Text] [Related]